MRSA SCREENING SYSTEM BEING DEVELOPED BY ONDINE BIOPHARMA CORPORATION (Wall Street Transcript via Yahoo! Finance)
67 WALL STREET, New York - June 1, 2009 - The Wall Street Transcript has just published its Biotechnology Report report offering a timely review of the sector to serious investors and industry executives. This 107 page feature contains expert industry commentary through in-depth interviews. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online .

Oculus Innovative Sciences Receives FDA Clearance For Microcyn(R) Skin And Wound Gel (Medical News Today)
Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Microcyn Skin and Wound Gel as both a prescription and over-the-counter formulation.

FDA Issues Advertising Guidelines On Product Risk Information (Medical News Today)
FDA on Tuesday posted on its Web site advertising guidelines for drugmakers and medical device manufacturers, offering suggestions on how to present risk information to health care professionals and consumers, the Wall Street Journal reports.